Topiramate Tablet, Film Coated
Product Images NDC 72789-443

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72789-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789443 Label (72789443)

72789443 Label (72789443)
Topiramate USP 50 mg film-coated tablets carton and label by PD-Rx Pharmaceuticals, Inc. The label indicates a 60-tablet count and includes the NDC 72789-443-60, lot number J24C25, and expiration date 01/2026. The packaging displays warnings, refill information, and patient medication guide instructions.*
FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)
A Kaplan-Meier curve chart displaying cumulative rates for time to first seizure over 500 days. Two groups are compared: Topiramate 50 mg/day and Topiramate 400 mg/day, with patient numbers indicated. The y-axis shows cumulative rates, and the x-axis represents time in days. A p-value of 0.0002 is noted on the chart.*
FDA Label Image

Figure 2 (Topiramate Fig2)

Figure 2 (Topiramate Fig2)
Bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate with Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day compared to placebo. Data are presented for two studies with significance indicators for p-values below 0.010 and 0.001.*
FDA Label Image

Chemical Structure (Topiramate Str)

Chemical Structure (Topiramate Str)
Chemical structure diagram of topiramate, depicting its molecular framework including sulfonamide and multiple methyl groups, consistent with the active ingredient topiramate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.